Target intelligence / Profile preview

Protein synthesis and folding machinery

Molecular classification
Enzyme (e.g., aminoacyl-tRNA synthetases), Ribosomal complex, Molecular chaperone, Other (since it refers collectively to several families)
01

Overview

The protein synthesis/folding machinery refers collectively to cellular components that synthesize and shape all functional proteins in a cell. Protein synthesis begins with the ribosome translating messenger RNA (mRNA) into polypeptides using tRNA adaptors and enzymatic factors. These newly made polypeptides require proper folding into their native conformation, a process guided and assisted by molecular chaperones (e.g., Hsp90, Hsp70). Chaperones prevent aggregation and misfolding, especially under cellular stress or when polypeptides are large or multidomain. Many antibiotics and anticancer agents exploit unique aspects of the protein synthesis or folding machinery to achieve selective toxicity[1][3][4][6]. This entry should be used with great caution for target annotation. For specific drug targets, always refer to individual machinery components (e.g., "Ribosome 50S subunit", "Heat shock protein 90") rather than to this collective term.

Other names
protein synthesis apparatustranslation machinerymolecular chaperonesribosome complexfolding chaperonestranslational machinery
02

Mechanism of action

Inhibition of ribosomal subunits (antibacterial action) Inhibition of chaperones (prevents protein folding, induces degradation; anticancer action) Modulation of translation or folding efficiency

03

Biological functions

Protein synthesisProtein folding and maturationPrevention of protein aggregationCellular stress responseProtein quality control
04

Disease associations

Cancer (dysregulation of chaperones like Hsp90)Infection (antibiotics targeting ribosomes)Neurodegenerative disease (misfolded protein handling; chaperones)Cardiovascular disease (rare, e.g., stress chaperones)
05

Safety considerations

Cytotoxicity due to inhibition of general protein synthesis/foldingOff-target effects caused by broad activityPotential for resistance (ribosome-targeting drugs)Protein aggregation/toxicity (impaired folding)
06

Interacting drugs

Antibiotics (e.g., aminoglycosides, macrolides, tetracyclines; target ribosomal subunits)

3 more in the full profile.

07

Biomarkers

Hsp90 levels/activity (in cancer)Ribosomal RNA or protein synthesis rates (infection/proliferation; research use)

Beyond the preview

Go deeper on Protein synthesis and folding machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein synthesis and folding machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call